Qingdao NovelBeam TechnologyLtd Future Growth
Future criteria checks 5/6
Qingdao NovelBeam TechnologyLtd is forecast to grow earnings and revenue by 31.3% and 27.6% per annum respectively. EPS is expected to grow by 31.1% per annum. Return on equity is forecast to be 16.4% in 3 years.
Key information
31.3%
Earnings growth rate
31.1%
EPS growth rate
Medical Equipment earnings growth | 23.7% |
Revenue growth rate | 27.6% |
Future return on equity | 16.4% |
Analyst coverage | Good |
Last updated | 10 May 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 961 | 344 | N/A | 307 | 3 |
12/31/2025 | 811 | 282 | N/A | 282 | 6 |
12/31/2024 | 611 | 213 | N/A | 207 | 3 |
3/31/2024 | 440 | 136 | 119 | 180 | N/A |
12/31/2023 | 471 | 146 | 102 | 158 | N/A |
9/30/2023 | 513 | 161 | 83 | 130 | N/A |
6/30/2023 | 548 | 192 | 69 | 118 | N/A |
3/31/2023 | 532 | 195 | 35 | 99 | N/A |
12/31/2022 | 477 | 183 | 3 | 104 | N/A |
9/30/2022 | 431 | 166 | -17 | 109 | N/A |
6/30/2022 | 370 | 139 | -28 | 108 | N/A |
3/31/2022 | 336 | 127 | -37 | 96 | N/A |
12/31/2021 | 310 | 118 | 4 | 104 | N/A |
9/30/2021 | 294 | 113 | 26 | 124 | N/A |
6/30/2021 | 276 | 105 | 43 | 136 | N/A |
3/31/2021 | 271 | 92 | 45 | 121 | N/A |
12/31/2020 | 275 | 96 | 46 | 115 | N/A |
9/30/2020 | 259 | 89 | 47 | 93 | N/A |
12/31/2019 | 253 | 72 | 43 | 84 | N/A |
12/31/2018 | 201 | 55 | 14 | 48 | N/A |
6/30/2018 | 166 | 39 | 39 | 48 | N/A |
3/31/2018 | 176 | 48 | 61 | 71 | N/A |
12/31/2017 | 181 | 51 | N/A | 66 | N/A |
9/30/2017 | 169 | 48 | N/A | 69 | N/A |
6/30/2017 | 159 | 46 | N/A | 67 | N/A |
12/31/2016 | 139 | 33 | N/A | 37 | N/A |
9/30/2016 | 129 | 30 | N/A | 27 | N/A |
6/30/2016 | 119 | 27 | N/A | 18 | N/A |
3/31/2016 | 97 | 21 | N/A | 17 | N/A |
12/31/2015 | 74 | 16 | N/A | 16 | N/A |
12/31/2014 | 68 | 7 | N/A | 14 | N/A |
12/31/2013 | 52 | -1 | N/A | 22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688677's forecast earnings growth (31.3% per year) is above the savings rate (2.9%).
Earnings vs Market: 688677's earnings (31.3% per year) are forecast to grow faster than the CN market (23.4% per year).
High Growth Earnings: 688677's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688677's revenue (27.6% per year) is forecast to grow faster than the CN market (14.1% per year).
High Growth Revenue: 688677's revenue (27.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688677's Return on Equity is forecast to be low in 3 years time (16.4%).